French President Emmanuel Macron/Photo = AP
–
French President Emmanuel Macron has raised doubts about the effectiveness of the novel coronavirus (Corona 19) vaccine by British pharmaceutical company AstraZeneca.
According to the AFP news agency, President Macron met with reporters on the 29th (local time) and said, “I think that it is invalid for people over 65 years old. We do not recommend AstraZeneca to people aged 60 to 65. The initial results obtained.”
The remarks came a few hours before the European Medicines Agency recommended conditional marketing approval for the AstraZeneca vaccine. It is reported that France will announce the approval of its own health authorities early next week.
In order to quickly spread the vaccine, the UK’s vaccination policy continued to extend the interval between the first and second doses to a maximum of 12 weeks.
In response, President Macron said, “Scientists explain that the mutant virus spreads because the virus adapts to less immunity with one dose. In addition, he insisted that it was “a lie” to say that he gave only the first vaccination and was’vaccinated’.
In response, the British Daily Telegraph reported that British political and scientific circles were criticizing President Macron’s remarks as “uncommon sense.”
Meanwhile, the British Daily Guardian and BBC broadcast on the 26th (hereafter local time), “European Medicines Agency (EMA) Commissioner Emma Cook attended the European Parliament’s Health Committee and approved “(AstraZeneca vaccine) to be used only by certain age groups It is possible to do it, and it can be made available to a wide range of age groups.
“Because there is not enough data on how this vaccine works for people over 65,” Cook said. “So far only a few studies have been conducted to see if it works for the elderly. Only a small number of studies have been conducted with a focus on specific age groups. There is a possibility that a conclusion will come to approve it.”
Earlier, criticism has been raised for the lack of clinical studies on the AstraZeneca vaccine in the elderly over the age of 55.
Jeongho Kim, guest reporter at Hankyung.com [email protected]
–
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution
–
